Acute RNA Viral Encephalomyelitis and the Role of Antibodies in the Central Nervous System

Viruses. 2020 Sep 5;12(9):988. doi: 10.3390/v12090988.

Abstract

Acute RNA viral encephalomyelitis is a serious complication of numerous virus infections. Antibodies in the cerebral spinal fluid (CSF) are correlated to better outcomes, and there is substantive evidence of antibody secreting cells (ASCs) entering the central nervous system (CNS) and contributing to resolution of infection. Here, we review the RNA viruses known to cause acute viral encephalomyelitis with mechanisms of control that require antibody or ASCs. We compile the cytokines, chemokines, and surface receptors associated with ASC recruitment to the CNS after infection and compare known antibody-mediated mechanisms as well as potential noncytolytic mechanisms for virus control. These non-canonical functions of antibodies may be employed in the CNS to protect precious non-renewable neurons. Understanding the immune-specialized zone of the CNS is essential for the development of effective treatments for acute encephalomyelitis caused by RNA viruses.

Keywords: antibodies; central nervous system; encephalomyelitis.

Publication types

  • Research Support, N.I.H., Extramural
  • Review

MeSH terms

  • Animals
  • Antibodies / immunology*
  • Central Nervous System / immunology*
  • Central Nervous System / virology
  • Encephalomyelitis / immunology
  • Encephalomyelitis / virology
  • Humans
  • RNA Virus Infections / immunology*
  • RNA Viruses / genetics
  • RNA Viruses / immunology
  • RNA Viruses / physiology*

Substances

  • Antibodies